In terms of clinical presentation, half of the MOG-seropositive (2/4) or AQP4-seropositive (16/31) patients and about two thirds (8/13) of the seronegative patients had an initial presentation with uni-/bilateral optic neuritis (ON) (Table 1). This evidence concerns the gene AQP4 and optic neuritis.